Bank of New York Mellon Corp
BankPosition in AKBA — Akebia Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in AKBA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$705,828
-$198,853 QoQ
Shares Held
619,149
-4.9% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 53 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. AKBA ranks #36 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,322,319 | $238,741,833 | |
| 2 | VTRS |
Viatris Inc
|
14,288,053 | $226,894,274 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
294,413 | $159,521,790 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
699,125 | $117,830,519 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,411,532 | $83,957,795 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,899,912 | $64,369,013 | |
| 7 | ALKS |
Alkermes plc.
|
1,097,282 | $57,497,573 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
441,831 | $49,016,724 |
All Filings in AKBA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $705,828 | 619,149 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $904,681 | 650,851 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,073,719 | 666,907 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,854,329 | 679,242 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,240,787 | 615,601 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $947,696 | 493,593 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $945,338 | 497,547 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $620,013 | 469,708 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $616,641 | 604,551 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $34,333 | 18,762 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $89,070 | 71,831 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $81,886 | 71,830 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $65,729 | 71,836 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $40,228 | 71,836 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $41,449 | 71,836 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $22,700 | 71,836 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $25,358 | 71,836 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $458,717 | 638,883 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,412,149 | 624,845 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $1,704,467 | 591,829 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,130,565 | 562,155 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,018,234 | 596,229 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $1,450,843 | 578,026 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $8,573,160 | 631,308 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $4,480,551 | 591,102 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||